ESC Professional Premium Access

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Topic: Epidemiology, Prognosis, Outcome

Congress Session

About the speaker

Doctor Roland Klingenberg

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)
0 follower

6 more presentations in this session

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor O. Wozniak (Warsaw, PL)

Thumbnail

Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Speaker: Doctor J. Cunningham (Boston, US)

Thumbnail

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Speaker: Doctor M. Iguchi (Kyoto, JP) Professor K. Hasegawa (Kyoto, JP)

Thumbnail

Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

Speaker: Doctor R. Pistulli (Munster, DE)

Thumbnail

Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Speaker: Mr C. Kelly (Newcastle, AU)

Thumbnail

Access the full session

Biomarkers for heart failure 1

Speakers: Doctor R. Klingenberg, Doctor O. Wozniak, Doctor J. Cunningham, Doctor M. Iguchi, Professor K. Hasegawa...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk